Clinical characteristic | N | % |
---|---|---|
Age | ||
  ≤ 65 | 190 | 37.9 |
  > 65 | 302 | 60.3 |
 NA | 9 | 1.8 |
Sex | ||
 Female | 130 | 25.9 |
 Male | 371 | 74.1 |
AJCC stage | ||
 I | 3 | 0.6 |
 IA | 90 | 18.0 |
 IB | 151 | 30.1 |
 II | 3 | 0.6 |
 IIA | 65 | 13.0 |
 IIB | 94 | 18.8 |
 III | 3 | 0.6 |
 IIIA | 63 | 12.6 |
 IIIB | 18 | 3.6 |
 IV | 7 | 1.4 |
 NA | 4 | 0.8 |
T | ||
 T1 | 114 | 22.7 |
 T2 | 293 | 58.5 |
 T3 | 71 | 14.2 |
 T4 | 23 | 4.6 |
N | ||
 N0 | 319 | 63.7 |
 N1 | 131 | 26.1 |
 N2 | 40 | 8.0 |
 N3 | 5 | 1.0 |
 NA | 6 | 1.2 |
M | ||
 M0 | 411 | 82.0 |
 M1 | 7 | 1.4 |
 NA | 83 | 16.6 |
Survival time | ||
 Reported | 495 | 98.8 |
 NA | 6 | 1.2 |
Survival status | ||
 Alive | 286 | 57.1 |
 Dead | 215 | 42.9 |